Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyrus Hedvat

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Cancer Research|January 14, 2010
Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemiasOmar Abdel-Wahab, Taghi Manshouri, Jay Patel, et al.
Immunity|October 22, 2002
The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cellsH Daniel Lacorazza, Yasushi Miyazaki, Antonio Di Cristofano, et al.
Annals of Surgical Oncology|July 2, 2009
T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastasesSteven C Katz, Venu Pillarisetty, Zubin M Bamboat, et al.
Cancer|March 15, 2006
Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosaRohit Bhargava, Beiyun Chen, David S Klimstra, et al.
Journal of Clinical Pathology|May 9, 2022
Development of a LAG-3 immunohistochemistry assay for melanomaLori Johnson, Bryan McCune, Darren Locke, et al.
Blood|March 21, 2012
Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcomeSu-Jiang Zhang, Raajit Rampal, Taghi Manshouri, et al.
The Journal of Clinical Investigation|September 21, 2010
HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humansSachie Marubayashi, Priya Koppikar, Tony Taldone, et al.
Blood|February 16, 2010
Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosisPriya Koppikar, Omar Abdel-Wahab, Cyrus Hedvat, et al.
Blood|December 6, 2011
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantationEkaterina Doubrovina, Banu Oflaz-Sozmen, Susan E Prockop, et al.
Science Translational Medicine|March 22, 2013
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemiaRenier J Brentjens, Marco L Davila, Isabelle Riviere, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Cancer Research|January 14, 2010
Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemiasOmar Abdel-Wahab, Taghi Manshouri, Jay Patel, et al.
Immunity|October 22, 2002
The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cellsH Daniel Lacorazza, Yasushi Miyazaki, Antonio Di Cristofano, et al.
Annals of Surgical Oncology|July 2, 2009
T cell infiltrate predicts long-term survival following resection of colorectal cancer liver metastasesSteven C Katz, Venu Pillarisetty, Zubin M Bamboat, et al.
Cancer|March 15, 2006
Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosaRohit Bhargava, Beiyun Chen, David S Klimstra, et al.
Journal of Clinical Pathology|May 9, 2022
Development of a LAG-3 immunohistochemistry assay for melanomaLori Johnson, Bryan McCune, Darren Locke, et al.
Blood|March 21, 2012
Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcomeSu-Jiang Zhang, Raajit Rampal, Taghi Manshouri, et al.
The Journal of Clinical Investigation|September 21, 2010
HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humansSachie Marubayashi, Priya Koppikar, Tony Taldone, et al.
Blood|February 16, 2010
Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosisPriya Koppikar, Omar Abdel-Wahab, Cyrus Hedvat, et al.
Blood|December 6, 2011
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantationEkaterina Doubrovina, Banu Oflaz-Sozmen, Susan E Prockop, et al.
Science Translational Medicine|March 22, 2013
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemiaRenier J Brentjens, Marco L Davila, Isabelle Riviere, et al.
Pageof 3